Skip to main content
Erschienen in: Social Psychiatry and Psychiatric Epidemiology 10/2007

01.10.2007 | ORIGINAL PAPER

Measurement of quality of life in schizophrenia: a comparison of two scales

verfasst von: Yvette Kusel, Dr. Richard Laugharne, Sian Perrington, Jan McKendrick, Deborah Stephenson, J. Stockton-Henderson, Madeline Barley, R. McCaul, Tom Burns

Erschienen in: Social Psychiatry and Psychiatric Epidemiology | Ausgabe 10/2007

Einloggen, um Zugang zu erhalten

Abstract

Background

People with schizophrenia have an impaired quality of life (QoL), and various QoL assessment scales are available. However it is not clear which scale should be used in different situations. We aimed to compare a patient-rated subjective QoL scale with an observer-rated QoL scale by measuring their degree of correlation and their respective associative profiles with outcome measures.

Method

Patients of the UK Schizophrenia Care and Assessment Program completed a patient-rated QoL questionnaire (MANSA). Research staff completed the observer-rated QoL tool (QLS) as part of an assessment of symptomatology and functioning.

Results

The two QoL tools were moderately positively correlated (r = 0.39). Both scales were negatively correlated with positive and negative symptoms of schizophrenia and depressive symptoms, and positively correlated with functioning scores. However the two scales were influenced by different factors. The patient-rated QoL was more significantly influenced by depressive symptoms, and the observer-rated QoL was more heavily influenced by negative symptoms.

Conclusions

Patient-rated and observer-rated QoL are moderately related, with a number of joint determinants, but the former is sensitive to depressive influences, whilst the latter is sensitive to the negative symptomatology of schizophrenia.
Literatur
1.
Zurück zum Zitat Sartorious N (1992) Rehabilitation and quality of life. Hosp Community Psychiatry 43:1180–1181 Sartorious N (1992) Rehabilitation and quality of life. Hosp Community Psychiatry 43:1180–1181
2.
Zurück zum Zitat Awad G, Varuganti L, Heslegrave R (1997) Measuring quality of life in patients with schizophrenia. PharmacoEconomics 11:32–47PubMed Awad G, Varuganti L, Heslegrave R (1997) Measuring quality of life in patients with schizophrenia. PharmacoEconomics 11:32–47PubMed
3.
Zurück zum Zitat Priebe S (2002) The quality of life construct in psychiatry-the state of the art. Int Rev Psychiatry 14:173–174CrossRef Priebe S (2002) The quality of life construct in psychiatry-the state of the art. Int Rev Psychiatry 14:173–174CrossRef
4.
Zurück zum Zitat Lehman AF, Ward N, Linn L (1982) Chronic mental patients: the quality of life issues. Am J Psychiatry 139:1271–1276PubMed Lehman AF, Ward N, Linn L (1982) Chronic mental patients: the quality of life issues. Am J Psychiatry 139:1271–1276PubMed
5.
Zurück zum Zitat Koivumaa-Honkanen HT, Honkanen R, Antikaninen R, et al. (1999) Self-reported life satisfaction and treatment factors in patients with schizophrenia, major depression, and anxiety disorder. Acta Psychiatr Scand 99:377–384PubMed Koivumaa-Honkanen HT, Honkanen R, Antikaninen R, et al. (1999) Self-reported life satisfaction and treatment factors in patients with schizophrenia, major depression, and anxiety disorder. Acta Psychiatr Scand 99:377–384PubMed
6.
Zurück zum Zitat Atkinson M, Zibin S, Chuang H (1997) Characterizing quality of life among patients with chronic mental illness: a critical examination of the self-report methodology. Am J Psychiatry 154:99–105PubMed Atkinson M, Zibin S, Chuang H (1997) Characterizing quality of life among patients with chronic mental illness: a critical examination of the self-report methodology. Am J Psychiatry 154:99–105PubMed
7.
Zurück zum Zitat Burns T, Christova L, Cooper S, Harrison G, Mckendrick J, Laugharne R, Obuaya T, Mccreadie R, O’Brien S, Perrington S, Stephenson D (2006) Maintenance antipsychotic medication patterns in outpatient schizophrenia patients: a naturalistic cohort study. Acta Psychiatr Scand 113:126–134PubMedCrossRef Burns T, Christova L, Cooper S, Harrison G, Mckendrick J, Laugharne R, Obuaya T, Mccreadie R, O’Brien S, Perrington S, Stephenson D (2006) Maintenance antipsychotic medication patterns in outpatient schizophrenia patients: a naturalistic cohort study. Acta Psychiatr Scand 113:126–134PubMedCrossRef
8.
Zurück zum Zitat American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders. 4th edn, DSM-IV. APA, Washington, DC American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders. 4th edn, DSM-IV. APA, Washington, DC
9.
Zurück zum Zitat Heinrichs DW, Hanlon TE, Carpenter WT (1984) The quality of life scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr Bull 10:388–398PubMed Heinrichs DW, Hanlon TE, Carpenter WT (1984) The quality of life scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr Bull 10:388–398PubMed
10.
Zurück zum Zitat Priebe S, Huxley P, Knight S, Evans S (1999) Application and results of the Manchester Short Assessment of Quality of Life (MANSA). Int J Soc Psychiatry 45: 7–12PubMedCrossRef Priebe S, Huxley P, Knight S, Evans S (1999) Application and results of the Manchester Short Assessment of Quality of Life (MANSA). Int J Soc Psychiatry 45: 7–12PubMedCrossRef
11.
Zurück zum Zitat Lehman AF (1983) The well-being of chronic mental patients: asessing their quality of life. Arch Gen Psychiatry 40:369–373PubMed Lehman AF (1983) The well-being of chronic mental patients: asessing their quality of life. Arch Gen Psychiatry 40:369–373PubMed
12.
Zurück zum Zitat Oliver JPJ (1991) The social care directive: development of a quality of life profile for use in community services for the mentally ill. Social Work Social Sci Rev 3:5–45 Oliver JPJ (1991) The social care directive: development of a quality of life profile for use in community services for the mentally ill. Social Work Social Sci Rev 3:5–45
13.
Zurück zum Zitat Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261–276PubMed Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261–276PubMed
14.
Zurück zum Zitat Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382–389PubMed Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382–389PubMed
15.
Zurück zum Zitat Guy W (1976) ECDEU assessment manual for psychopharmacology, Revised Edition, US Department of Health, Education and Welfare, Washington, DC Guy W (1976) ECDEU assessment manual for psychopharmacology, Revised Edition, US Department of Health, Education and Welfare, Washington, DC
16.
Zurück zum Zitat Simpson GM, Angus JW (1970) A rating scale for extrapyramidal side effects. Acta Psychiatr Scand 212:11–19CrossRef Simpson GM, Angus JW (1970) A rating scale for extrapyramidal side effects. Acta Psychiatr Scand 212:11–19CrossRef
17.
18.
Zurück zum Zitat Wilkinson G, Hesdon B, Wild D, et al. (2000) Self-report quality of life measure for people with schizophrenia: the SQLS. Br J Psychiatry 177:42–46PubMedCrossRef Wilkinson G, Hesdon B, Wild D, et al. (2000) Self-report quality of life measure for people with schizophrenia: the SQLS. Br J Psychiatry 177:42–46PubMedCrossRef
19.
Zurück zum Zitat Swinscow TDV (1996) Statistics at square one. BMJ Publishing Group, London Swinscow TDV (1996) Statistics at square one. BMJ Publishing Group, London
20.
Zurück zum Zitat Fakhoury WKH, Priebe S (2002) Subjective quality of life: its association with other constructs. Int Rev Psychiatry 14:219–224CrossRef Fakhoury WKH, Priebe S (2002) Subjective quality of life: its association with other constructs. Int Rev Psychiatry 14:219–224CrossRef
21.
Zurück zum Zitat Cramer JA, Rosenheck R, Xu W, et al. (2000) Quality of life in schizophrenia: a comparison of instruments. Schizophr Bull 26:659–666PubMed Cramer JA, Rosenheck R, Xu W, et al. (2000) Quality of life in schizophrenia: a comparison of instruments. Schizophr Bull 26:659–666PubMed
22.
Zurück zum Zitat Holloway F, Carson J (2002) Quality of life in severe mental illness. Int Rev Psychiatry 14:175–184CrossRef Holloway F, Carson J (2002) Quality of life in severe mental illness. Int Rev Psychiatry 14:175–184CrossRef
23.
Zurück zum Zitat Fitzgerald PB, Williams CL Corteling N, Filia SL Brewer K, Adams A, De Castella AR, Rolfe T, Davey P, Kulkarni J (2001) Subject and observer rated quality of life in schizophrenia. Acta Psychiatr Scand 103:387–392PubMedCrossRef Fitzgerald PB, Williams CL Corteling N, Filia SL Brewer K, Adams A, De Castella AR, Rolfe T, Davey P, Kulkarni J (2001) Subject and observer rated quality of life in schizophrenia. Acta Psychiatr Scand 103:387–392PubMedCrossRef
24.
Zurück zum Zitat Priebe S, Roeder-Wanner U, Kaiser W (2000) Quality of life in first admitted schizophrenia patients: a follow up study. Psychol Med 30:225–230PubMedCrossRef Priebe S, Roeder-Wanner U, Kaiser W (2000) Quality of life in first admitted schizophrenia patients: a follow up study. Psychol Med 30:225–230PubMedCrossRef
25.
Zurück zum Zitat Dickerson FB, Ringel NB, Parente F (1998) Subjective quality of life, in outpatients with schizophrenia: clinical and utilisation correlates. Acta Psychiatr Scand 98:124–127PubMed Dickerson FB, Ringel NB, Parente F (1998) Subjective quality of life, in outpatients with schizophrenia: clinical and utilisation correlates. Acta Psychiatr Scand 98:124–127PubMed
26.
Zurück zum Zitat Browne S, Clarke M, Gervin M, Waddington J, Larkin C, O’Callaghan E (2000) Determinants of quality of life at first presentation with schizophrenia. Br J Psychiatry 176:173–176PubMedCrossRef Browne S, Clarke M, Gervin M, Waddington J, Larkin C, O’Callaghan E (2000) Determinants of quality of life at first presentation with schizophrenia. Br J Psychiatry 176:173–176PubMedCrossRef
27.
Zurück zum Zitat Bow-Thomas C, Velligan DI, Miller AL, Olsen J (1999) Predicting quality of life from symptomatology in schizophrenia at exacerbation and stabilisation. Psychiatry Res 86:131–142PubMedCrossRef Bow-Thomas C, Velligan DI, Miller AL, Olsen J (1999) Predicting quality of life from symptomatology in schizophrenia at exacerbation and stabilisation. Psychiatry Res 86:131–142PubMedCrossRef
28.
Zurück zum Zitat Norman RM, Malla MK, McLean T, Voruganti LP, Cortese L, et al. (2000) The relationship of symptoms and level of functioning in schizophrenia to general wellbeing and the Quality of Life Scale. Acta Psychiatr Scand 102:303–309PubMedCrossRef Norman RM, Malla MK, McLean T, Voruganti LP, Cortese L, et al. (2000) The relationship of symptoms and level of functioning in schizophrenia to general wellbeing and the Quality of Life Scale. Acta Psychiatr Scand 102:303–309PubMedCrossRef
Metadaten
Titel
Measurement of quality of life in schizophrenia: a comparison of two scales
verfasst von
Yvette Kusel
Dr. Richard Laugharne
Sian Perrington
Jan McKendrick
Deborah Stephenson
J. Stockton-Henderson
Madeline Barley
R. McCaul
Tom Burns
Publikationsdatum
01.10.2007
Verlag
D. Steinkopff-Verlag
Erschienen in
Social Psychiatry and Psychiatric Epidemiology / Ausgabe 10/2007
Print ISSN: 0933-7954
Elektronische ISSN: 1433-9285
DOI
https://doi.org/10.1007/s00127-007-0249-1

Weitere Artikel der Ausgabe 10/2007

Social Psychiatry and Psychiatric Epidemiology 10/2007 Zur Ausgabe

Prämenstruelle Beschwerden mit Suizidrisiko assoziiert

04.06.2024 Suizidalität Nachrichten

Manche Frauen, die regelmäßig psychische und körperliche Symptome vor ihrer Menstruation erleben, haben ein deutlich erhöhtes Suizidrisiko. Jüngere Frauen sind besonders gefährdet.

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Demenzkranke durch Antipsychotika vielfach gefährdet

Demenz Nachrichten

Der Einsatz von Antipsychotika gegen psychische und Verhaltenssymptome in Zusammenhang mit Demenzerkrankungen erfordert eine sorgfältige Nutzen-Risiken-Abwägung. Neuen Erkenntnissen zufolge sind auf der Risikoseite weitere schwerwiegende Ereignisse zu berücksichtigen.

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.